She is also co-host of the weekly biotech podcast, The Readout Loud. You can reach Allison on Signal at AllisonDeAngelis.01. ARCH Venture Partners has raised $3 billion for a new fund — one of ...

Two ‘Firefly petunias’ perished in a shipping misadventure, but other customers have had better luck. This article first appeared in The Checkup, MIT Technology Review’s weekly biotech ...

The S&P Biotech ETF is also down 55% since peaking just after Arch’s January 2021 haul, from more than $166 per share to just $74 today. In a statement, Arch Co-founder and Managing Director ...

For $73, I bought genetically modified tomato seeds and a glowing petunia. This spring I am looking forward to growing some biotech in my backyard for the first time. It’s possible because of ...

Williams previously served as CEO and co-founder of ImmusanT, another Arch Venture Partners-backed biotech. The company stopped a phase 2 trial of its celiac disease program in June 2019 after an ...

ARCH Venture Partners has closed a $2.975 billion fund targeted for early-stage biotech companies. The firm’s 12th venture fund comes on the heels of a nearly $2 billion fund announced in ...

That’s true of her work at ARCH Venture Partners ... Burow also sits on the boards of several emerging biotech companies, helping to steer how they stress-test their science and what types ...

This 20-year goal will see investments of $1.2 billion in bio industrial domestic manufacturing for biotech innovators ... Organizations, such as the Plant Based Products Council, are advocating ...

Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million manufacturing plant in Wake County, creating over 400 new jobs, Governor Josh Stein announced Monday.